Supriya Lifescience Limited

NSEI:SUPRIYA Rapporto sulle azioni

Cap. di mercato: ₹50.8b

Supriya Lifescience Crescita futura

Future criteri di controllo 3/6

Supriya Lifescience is forecast to grow earnings and revenue by 14.3% and 20.7% per annum respectively. EPS is expected to grow by 14.4% per annum. Return on equity is forecast to be 16% in 3 years.

Informazioni chiave

14.3%

Tasso di crescita degli utili

14.4%

Tasso di crescita dell'EPS

Pharmaceuticals crescita degli utili18.4%
Tasso di crescita dei ricavi20.7%
Rendimento futuro del capitale proprio16.0%
Copertura analitica

Low

Ultimo aggiornamento29 Oct 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Supriya Lifescience (NSE:SUPRIYA) Has Announced That It Will Be Increasing Its Dividend To ₹0.80

Sep 08
Supriya Lifescience (NSE:SUPRIYA) Has Announced That It Will Be Increasing Its Dividend To ₹0.80

We Think You Should Be Aware Of Some Concerning Factors In Supriya Lifescience's (NSE:SUPRIYA) Earnings

Jun 05
We Think You Should Be Aware Of Some Concerning Factors In Supriya Lifescience's (NSE:SUPRIYA) Earnings

Little Excitement Around Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings

May 10
Little Excitement Around Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings

Lacklustre Performance Is Driving Supriya Lifescience Limited's (NSE:SUPRIYA) Low P/E

Feb 09
Lacklustre Performance Is Driving Supriya Lifescience Limited's (NSE:SUPRIYA) Low P/E

Supriya Lifescience's (NSE:SUPRIYA) Shareholders May Want To Dig Deeper Than Statutory Profit

May 28
Supriya Lifescience's (NSE:SUPRIYA) Shareholders May Want To Dig Deeper Than Statutory Profit

Market Cool On Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings Pushing Shares 27% Lower

May 07
Market Cool On Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings Pushing Shares 27% Lower

Previsioni di crescita degli utili e dei ricavi

NSEI:SUPRIYA - Stime future degli analisti e dati finanziari passati (INR Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
3/31/202710,3452,214N/A1,6781
3/31/20268,4101,788N/A1,3681
3/31/20256,8381,596N/A1,3361
9/30/20246,2501,575-1891,495N/A
6/30/20245,9901,352N/AN/AN/A
3/31/20245,7041,191-3231,133N/A
12/31/20235,5451,204N/AN/AN/A
9/30/20235,1951,001721,322N/A
6/30/20234,916931N/AN/AN/A
3/31/20234,609899-443636N/A
12/31/20225,069978N/AN/AN/A
9/30/20225,1881,280-191226N/A
6/30/20225,5451,693N/AN/AN/A
3/31/20225,3001,518-111488N/A
12/31/20214,7541,543N/AN/AN/A
3/31/20213,9121,236276759N/A
3/31/20203,2007349151,161N/A
3/31/20192,818394417487N/A
3/31/20182,16887N/A278N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: SUPRIYA's forecast earnings growth (14.3% per year) is above the savings rate (6.7%).

Guadagni vs Mercato: SUPRIYA's earnings (14.3% per year) are forecast to grow slower than the Indian market (18.1% per year).

Guadagni ad alta crescita: SUPRIYA's earnings are forecast to grow, but not significantly.

Ricavi vs Mercato: SUPRIYA's revenue (20.7% per year) is forecast to grow faster than the Indian market (10.2% per year).

Ricavi ad alta crescita: SUPRIYA's revenue (20.7% per year) is forecast to grow faster than 20% per year.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: SUPRIYA's Return on Equity is forecast to be low in 3 years time (16%).


Scoprire le aziende in crescita